Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2021202020192018201720162015201420132012201120102009200820072006 Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin Plus Nivolumab in 'Cancer Discovery' Journal May 22, 2020 Nektar Therapeutics Reports First Quarter 2020 Financial Results May 07, 2020 Nektar to Announce Financial Results for the First Quarter 2020 on Thursday, May 7, 2020, After Close of U.S.-Based Financial Markets Apr 28, 2020 Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference Feb 28, 2020 Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results Feb 27, 2020 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2019 on Thursday, February 27, 2020, After Close of U.S.-Based Financial Markets Feb 18, 2020 Nektar Therapeutics Announces Publication of Two Manuscripts on Lead Immuno-oncology Candidate, Bempegaldesleukin (Bempeg) in Nature Communications Feb 03, 2020 Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol Jan 14, 2020 Nektar Therapeutics and Bristol-Myers Squibb Amend Strategic Collaboration Agreement for bempegaldesleukin Plus Opdivo (nivolumab) Jan 10, 2020 Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 07, 2020 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »